{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:38:03Z","timestamp":1765827483912},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ejso.2016.05.007","type":"journal-article","created":{"date-parts":[[2016,5,25]],"date-time":"2016-05-25T23:06:16Z","timestamp":1464217576000},"page":"1162-1168","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Potential impact of application of Z0011 derived criteria to omit axillary lymph node dissection in node positive breast cancer patients"],"prefix":"10.1016","volume":"42","author":[{"given":"N.C.","family":"Verheuvel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C.","family":"Voogd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.C.G.","family":"Tjan-Heijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.H.","family":"Roumen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 6","key":"10.1016\/j.ejso.2016.05.007_bib1","doi-asserted-by":"crossref","first-page":"vi7","DOI":"10.1093\/annonc\/mdt284","article-title":"Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Senkus","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2016.05.007_bib2","series-title":"Comprehensive cancer centre Netherlands","author":"NABON national guideline breast cancer 2.0","year":"2012"},{"issue":"2016","key":"10.1016\/j.ejso.2016.05.007_bib3","article-title":"NCCN clinical practice guidelines in oncology (NCCN Guidelines)","volume":"1","author":"National Comprehensive Cancer Network","year":"2016","journal-title":"Breast Cancer"},{"key":"10.1016\/j.ejso.2016.05.007_bib4","doi-asserted-by":"crossref","first-page":"b438","DOI":"10.1136\/bmj.b438","article-title":"Diagnosis and treatment of early breast cancer, including locally advanced disease\u2013summary of NICE guidance","volume":"338","author":"Harnett","year":"2009","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ejso.2016.05.007_bib5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s12253-009-9177-6","article-title":"Predicting non-sentinel lymph node status after positive sentinel biopsy in breast cancer: what model performs the best in a Czech population?","volume":"15","author":"Coufal","year":"2009","journal-title":"Pathol Oncol Res"},{"issue":"4","key":"10.1016\/j.ejso.2016.05.007_bib6","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.amjsurg.2006.06.016","article-title":"The likelihood of additional nodal disease following a positive sentinel lymph node biopsy in breast cancer patients: validation of a nomogram","volume":"192","author":"Cripe","year":"2006","journal-title":"Am J Surg"},{"issue":"17","key":"10.1016\/j.ejso.2016.05.007_bib7","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1200\/JCO.2008.19.7418","article-title":"Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study","volume":"27","author":"Coutant","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2016.05.007_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jamcollsurg.2008.10.029","article-title":"Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy","volume":"208","author":"Gur","year":"2009","journal-title":"J\u00a0Am Coll Surg"},{"issue":"5","key":"10.1016\/j.ejso.2016.05.007_bib9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.amjsurg.2006.11.035","article-title":"Comparison of different validation studies on the use of the Memorial-Sloan Kettering Cancer Center nomogram predicting nonsentinel node involvement in sentinel node-positive breast cancer patients","volume":"194","author":"Cserni","year":"2007","journal-title":"Am J Surg"},{"issue":"22","key":"10.1016\/j.ejso.2016.05.007_bib10","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/jnci\/djn343","article-title":"Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node","volume":"100","author":"van Deurzen","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.ejso.2016.05.007_bib11","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ijrobp.2008.12.028","article-title":"Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study","volume":"75","author":"Unal","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.ejso.2016.05.007_bib12","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1245\/ASO.2003.03.015","article-title":"A\u00a0nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy","volume":"10","author":"Van Zee","year":"2003","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2016.05.007_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2016.05.007_bib14","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2016.05.007_bib15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","article-title":"Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial","volume":"252","author":"Giuliano","year":"2010","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.ejso.2016.05.007_bib16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ejso.2016.05.007_bib17","first-page":"1","article-title":"Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND) \u2013 ACOSOG Z0011 results and beyond","author":"Gatzemeier","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.ejso.2016.05.007_bib18","doi-asserted-by":"crossref","first-page":"355s","DOI":"10.1158\/0008-5472.SABCS11-P3-07-01","article-title":"Are the findings of ACOSOG Z0011 applicable to district general hospital unit- and how should they change our practice","volume":"71","author":"Olsen","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2016.05.007_bib19","doi-asserted-by":"crossref","first-page":"s11","DOI":"10.1016\/j.ejso.2011.03.043","article-title":"ACOSOG Z0011: are the results applicable to patients undergoing sentinel node biopsy in a UK breast unit","volume":"37","author":"Wen-Chan Yeow","year":"2011","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2016.05.007_bib20","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/ans.12388","article-title":"Relevance of the American College of Surgeons Oncology Group Z0011 trial to breast cancer in the Australian setting","volume":"83","author":"Ngui","year":"2013","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.ejso.2016.05.007_bib21","doi-asserted-by":"crossref","first-page":"366s","DOI":"10.1158\/0008-5472.SABCS11-P3-07-26","article-title":"How generalizable is the patient population enrolled in ACOSOG Z11?","volume":"71","author":"Lannin","year":"2011","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.ejso.2016.05.007_bib22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.ejso.2012.04.018","article-title":"The post ACOSOG Z0011 era: does our new understanding of breast cancer really change clinical practice?","volume":"38","author":"Guth","year":"2012","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2016.05.007_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jamcollsurg.2012.09.005","article-title":"Impact of the American college of surgeons oncology group Z0011 criteria applied to a contemporary patient population","volume":"216","author":"Yi","year":"2013","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2016.05.007_bib24","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1245\/s10434-013-2917-6","article-title":"The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter study","volume":"20","author":"Delpech","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2016.05.007_bib25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.breast.2012.11.005","article-title":"The clinical impact of the American College of Surgeons Oncology Group Z-0011 trial \u2013 results from the BreastSurgANZ National Breast Cancer Audit","volume":"22","author":"Ainsworth","year":"2013","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.ejso.2016.05.007_bib26","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jamcollsurg.2004.09.010","article-title":"Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?","volume":"200","author":"Specht","year":"2005","journal-title":"J\u00a0Am Coll Surg"},{"issue":"1","key":"10.1016\/j.ejso.2016.05.007_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1006447825160","article-title":"The risk of nodal metastases in breast cancer patients with clinically negative lymph nodes: a population-based analysis","volume":"62","author":"Voogd","year":"2000","journal-title":"Breast Cancer Res Treat"},{"issue":"Suppl. 1","key":"10.1016\/j.ejso.2016.05.007_bib28","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1007\/s00259-004-1531-z","article-title":"FDG-PET for axillary lymph node staging in primary breast cancer","volume":"31","author":"Crippa","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.ejso.2016.05.007_bib29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2214\/AJR.11.7702","article-title":"Preoperative needle biopsy of sentinel lymph nodes using intradermal microbubbles and contrast-enhanced ultrasound in patients with breast cancer","volume":"199","author":"Sever","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.ejso.2016.05.007_bib30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2016.05.007_bib31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1245\/s10434-014-4071-1","article-title":"The role of ultrasound-guided lymph node biopsy in axillary staging of invasive breast cancer in the post-ACOSOG Z0011 trial era","volume":"22","author":"Verheuvel","year":"2015","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798316301573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798316301573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T15:41:16Z","timestamp":1656603676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798316301573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0748798316301573"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2016.05.007","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential impact of application of Z0011 derived criteria to omit axillary lymph node dissection in node positive breast cancer patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2016.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}